Abbvie Total Revenue

The latest total revenue for ABBV is $64B as of June 2026. That compares with $58B in the prior-year period — up 10.4% year over year. That is below the Healthcare sector average of $110B. Investors often review this figure alongside Abbvie's historical trend and sector peers before judging valuation or financial health.

Over the past year, ABBV's total revenue moved from $58B to $64B — a 10.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Abbvie's operating scale or balance-sheet position.

Against Healthcare companies, ABBV currently prints $64B for total revenue, while the sector average sits near $110B. That is roughly 42.6% below the sector mean. Large gaps often invite a closer look at Abbvie's growth, margins, and balance sheet.

A total revenue figure of $64B for ABBV is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $110B. Explore the charts below for those layers of context.

After noting ABBV's total revenue ($64B), review year-over-year change from $58B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.